If they announce that enrollment for p2 m2m has increased that will be enough to make me happy. Anything else on top of that I'll consider extra.

The only thing that matters to me right now is completing the p2 trial and getting top line results out.

The timing has lined up for CYDY.

NEJM journal on Friday saying that REM is practically useless.

Twitter today by WHO halting HCQ trials due to safety.

Media gradually picking up our story - MSN / SF chronicle today

The other effective trials are stem cell based. Won't be viably scalable treatments for pandemic.

MEXICO expressing GREAT interest (read between the lines 30 patient trial? Formality. Will enroll that in a day in Mexico).

2 front runners failed. Other potentials not practical. Mexican NIH putting pressure on our FDA.

Cydy is ahead of the pack. But ONLY if we finish p2 enrollment.

Some extremely strange stage has been set for the lead actor, CYDY to take center stage and blow the roof of this btihc.

So again, all I need to see is increased enrollment. Because I see the circumstances aligning.